ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG Oral Capsule [PreserVision with Lutein]
RxNorm concept 891820, branded drug (sbd). Prescribable name: PreserVision with Lutein (ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG) Oral Capsule.
- RxCUI
- 891820
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/891820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
PreserVision with Lutein (ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG) Oral Capsule; vit-C 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / Lutein 5 MG / ZNO 34.8 MG Oral Capsule [PreserVision with Lutein]; vitamin C 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / Lutein 5 MG / ZNO 34.8 MG Oral Capsule [PreserVision with Lutein]
Related concepts
- lutein 5 MG (SCDC, consists of)
- ascorbic acid 226 MG (SCDC, consists of)
- cuprous oxide 0.8 MG (SCDC, consists of)
- dl-alpha tocopheryl acetate 200 UNT (SCDC, consists of)
- zinc oxide 34.8 MG (SCDC, consists of)
- ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG [PreserVision with Lutein] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- PreserVision with Lutein (BN, has ingredient)
- ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 24208063210
- 24208063211
- 24208063261
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 891820 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/891820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 891820. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.